What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His main research concerns Internal medicine, Immunology, Chemotherapy, Surgery and Oncology.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Acquired immunodeficiency syndrome.
Within one scientific family, he focuses on topics pertaining to Sarcoma under Acquired immunodeficiency syndrome, and may sometimes address concerns connected to Kaposi's sarcoma, Disease, Viral load, Immune reconstitution inflammatory syndrome and Hazard ratio.
The study incorporates disciplines such as Regimen, AIDS-related lymphoma and Cohort in addition to Immunology.
His work deals with themes such as Pregnancy, Radiation therapy and Toxicity, which intersect with Chemotherapy.
The various areas that Mark Bower examines in his Oncology study include Opportunistic infection, Germinoma and Sepsis.
His most cited work include:
- A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. (438 citations)
- Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas (326 citations)
- Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection (277 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Immunology, Oncology, Acquired immunodeficiency syndrome and Chemotherapy.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Surgery.
His Immunology research incorporates themes from Sarcoma and Virology.
His research in the fields of Lung cancer overlaps with other disciplines such as In patient.
Mark Bower interconnects Viral disease, Cohort study and Cohort in the investigation of issues within Acquired immunodeficiency syndrome.
As part of his studies on Chemotherapy, Mark Bower frequently links adjacent subjects like Methotrexate.
He most often published in these fields:
- Internal medicine (50.86%)
- Immunology (35.56%)
- Oncology (25.86%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (50.86%)
- Oncology (25.86%)
- Cancer (12.72%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer, Lymphoma and Immunology.
His Internal medicine research focuses on Gastroenterology and how it connects with Pathology.
His Oncology study which covers Surgery that intersects with Anal cancer.
His biological study spans a wide range of topics, including Prospective cohort study and Viral load.
Mark Bower combines subjects such as Chemotherapy and Hazard ratio with his study of Immunology.
His studies in Chemotherapy integrate themes in fields like Anthracycline and Rituximab.
Between 2013 and 2021, his most popular works were:
- British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.). (171 citations)
- British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.). (171 citations)
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer. (117 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His scientific interests lie mostly in Internal medicine, Oncology, Cancer, Immunology and Surgery.
Internal medicine is represented through his Survival analysis, Chemotherapy, Disease, Stage and Cervical cancer research.
His Oncology research incorporates elements of Clinical trial, Lymphoma, Cirrhosis, Hepatocellular carcinoma and Dosing.
The concepts of his Cancer study are interwoven with issues in Adverse effect, Pandemic, Incidence and Anoscopy.
His Immunology research includes elements of Routine clinical practice, Antibiotic therapy, Antibiotics and Hazard ratio.
Mark Bower has researched Surgery in several fields, including Anal Squamous Cell Carcinoma and Erlotinib.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
